| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Technology Officer | Chief Technical Officer
2 companies
Plavsic Mark is a Chief Technology Officer at Aura Biosciences, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $1.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 2025 | AURA Aura Biosciences, Inc. | Chief Technology Officer | Sell | 12,169 | $6.35 | $77,273.15 | -5.8% | -15.0% | - | |
| Feb 18, 2025 | AURA Aura Biosciences, Inc. | Chief Technology Officer | Sell | 2,151 | $7.75 | $16,670.25 | -1.0% | -22.6% | -34.1% | |
| Oct 16, 2024 | AURA Aura Biosciences, Inc. | Chief Technology Officer | Sell | 7,383 | $9.85 | $72,722.55 | -5.7% | -26.2% | -39.6% | |
| Jan 10, 2023 | FATE Fate Therapeutics Inc | Chief Technical Officer | Sell | 3,418 | $5.24 | $17,910.32 | -2.7% | -0.2% | -16.8% | |
| Jul 5, 2022 | FATE Fate Therapeutics Inc | Chief Technical Officer | Sell | 3,719 | $24.61 | $91,524.59 | -2.8% | -22.1% | -83.3% |